- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 357.26M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $585M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $584.31M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $139.3M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $160.39M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $774.18M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $791.62M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $449.56M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $599.48M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.72B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.94B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 262.36M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $2M |
| Capex | Q1 2025 · Mar 31, 2024 | $57.31M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$57.85M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $688.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $597.17M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.48B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.89B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.81 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.82 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $57.65M |
| Net Income | Q1 2025 · Mar 31, 2024 | $211.78M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $203.94M |
| Revenue | Q1 2025 · Mar 31, 2024 | $79.3M |